Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Beleave Inc BLEVF

Beleave Inc is a vertically integrated Canadian cannabis company. It operates streamlined facilities throughout Canada to cultivate high quality cannabis flower, oil and extracts with funded capacity more than 150,000 kilograms per year. Fully licensed to cultivate and sell medical and recreational cannabis, it is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. The company is currently developing new product lines as the recreational market is expected to allow for food and beverage-based cannabis products.


GREY:BLEVF - Post by User

Bullboard Posts
Comment by NEWBIEVESTORon Aug 23, 2018 12:39am
75 Views
Post# 28503721

RE:RE:Hip vs BE this week

RE:RE:Hip vs BE this week
linguinee wrote: Is the breakdown that simple? Are there any extentuations or expected developments influencing the valuations?


HIP had celebrity endorsement (tragically hip), the buy out offer from medrelief? I think it was. So it got a lot of attention. What has BE had? Nothing special so no one cares/knows about it.

I do believe HIP is over valued at this point in the game, it’s just so easy to compare with BE. HEXO has a $800mil enterprise value, 4x forecasted production than HIP and will be done in 2018, 20k kg supply deal, lowest cost producer @ $0.87/gram and Molson deal on top of it. So I don’t get why people would buy HIP when comparables like that are around. 


Bullboard Posts